Skip to main content
Log in

Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: Do they have a relationship with the prognosis of these patients?

  • Rapid Communication
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Introduction

The prognosis of MEN 1 patients is not only determined by pancreatic disease; it is also related to other uncommon tumors. The objective of this study is to analyze the tumors associated with MEN 1 outside the classic triad and to investigate their relationship with mortality.

Materials and methods

One hundred and five MEN 1 patients were studied in a tertiary referral hospital (1980–2019).

Results

With a follow-up of 11 ± 4 years, seven patients died (8%), four as a consequence MEN syndrome. Thirty-three percent had adrenal gland tumors. One patient died of adrenal cancer. Eight percent presented with a neuroendocrine thoracic neoplasm, and one patient died. Another patient died due to cutaneous T-cell lymphoma. A further patient died because of a gastrinoma with liver metastasis.

Conclusions

To conclude, 75% of MEN-related deaths were the result of an uncommon pathology, and we, therefore, recommend that these tumors should be taken into account in the screening and follow-up of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P et al (2010) Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg 34:249–255

    Article  Google Scholar 

  2. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA, Norton JA (1998) Lethality of multiple endocrine neoplasia type I. World J Surg 22:581–586

    Article  CAS  Google Scholar 

  3. Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR et al (2012) Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990–3011

    Article  CAS  Google Scholar 

  4. Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, Rohmer V et al (2012) Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des tumeurs endocrines database. Eur J Endocrinol 166:269–279

    Article  CAS  Google Scholar 

  5. Febrero B, Ríos A, Rodríguez JM (2017) Aggressive adrenal carcinoma in a young patient with multiple endocrine neoplasia 1 syndrome. Med Clin (Barc) 149:463

    Article  Google Scholar 

  6. Goudet P, Murat A, Cardot-Bauters C, Emy P, Baudin E, du Boullay CH et al (2009) Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN 1 from the GTE (Groupe des Tumeurs Endocrines). World J Surg 33:1197–1207

    Article  Google Scholar 

  7. Ye L, Wang W, Ospina NS, Jiang L, Christakis I, Lu J et al (2017) Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: a single-centre study, systematic review and meta-analysis. Clin Endocrinol (Oxf) 87(6):706–716

    Article  CAS  Google Scholar 

  8. Yeh JE, Tahan SR, Burgin S (2017) Folliculin mutation-negative trichodiscomas in a patient with multiple endocine neoplasia type I syndrome. Dermatol Online J 23(8).

  9. van Leeuwaarde RS, Dreijerink KM, Ausems MG, Beijers HJ, Dekkers OM, de Herder WW et al (2017) MEN1-dependent breast cancer: indication for early screening? results from the dutch MEN1 study group. J Clin Endocrinol Metab 102:2083–2090

    Article  Google Scholar 

  10. Jhawar S, Lakhotia R, Suzuki M, Welch J, Agarwal SK, Sharretts J et al (2019) Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1. Endocrinol Diabetes Metab Case Rep 19:0040

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Febrero.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants

For this type of study, formal consent is not required.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Febrero, B., Segura, P., Ruiz-Manzanera, J.J. et al. Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: Do they have a relationship with the prognosis of these patients?. J Endocrinol Invest 44, 1327–1330 (2021). https://doi.org/10.1007/s40618-020-01414-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-020-01414-2

Keywords

Navigation